Ivan P. Gergel, SVP & Chief Medical Officer at NEKTAR THERAPEUTICS (NKTR), sold 100,000 shares at $24.04 ($2.4M) on 2017-09-29, disclosed to the SEC on 2017-10-03.
Open-market sale of $2.4M NKTR by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.04 | 43,296 | $1.0M | 43.1% |
| 2 | $24.21 | 56,704 | $1.4M | 56.9% |
| Total | $24.14 avg | 100,000 | $2.4M | 100% |